Morning Overview on MSN
Study links anti-tumor immunity to autoimmune risks like anti-NMDA encephalitis
Immune checkpoint inhibitors have reshaped cancer treatment over the past decade, but the same immune activation that shrinks tumors can also turn against healthy tissue, including the brain. A ...
Patients with RA who use abatacept mount little humoral or cell-mediated responses to the recombinant zoster vaccine, with more injection-site reactions but similar RA flare rates compared with ...
New research suggests the skin does much more than detect damage or keep pathogens out. By tracing how skin cells respond to ...
This new article publication from Acta Pharmaceutica Sinica B, discusses how an innovative and stable mRNA-LNP microneedle vaccine elicits humoral and multifunctional cellular immune responses. During ...
A collaborative effort led by Professor Wanli Liu 's team at Tsinghua University has uncovered a sophisticated mechanism by ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, ...
In a paradigm breaking study, Dr. Pavan Reddy, director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of ...
Among adults aged 18 to 49 with chronic conditions at risk for RSV, the AS01E-adjuvanted RSVPreF3 vaccine elicits robust immune responses.
Morning Overview on MSN
Engineered lipid nanoparticles reprogram immune metabolism to boost mRNA
Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results